SureTrader
Home > Boards > US Listed > Medical - Drugs >

Athenex (ATNX)

ATNX RSS Feed
Add ATNX Price Alert      Hide Sticky   Hide Intro
Moderator: Leotrader211
Search This Board: 
Last Post: 2/13/2018 9:37:08 PM - Followers: 2 - Board type: Free - Posts Today: 0

New message board for Athenex
SureTrader
ATNX
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
SureTrader
ATNX News: Athenex Announces Phase II Clinical Study Results for KX2-391 Ointment for the Treatment of Actinic Keratosis in the American... 02/20/2018 08:11:23 AM
ATNX News: Athenex to Present at 2018 RBC Capital Markets Healthcare Conference 02/16/2018 08:00:00 AM
ATNX News: Athenex Meets Enrollment Target for Oraxol Phase III Clinical Trial in Metastatic Breast Cancer 02/15/2018 08:00:00 AM
ATNX News: Athenex Announces Early Completion of Patients Enrollment for Two Phase III Clinical Studies of KX2-391 Ointment for Actinic ... 02/14/2018 08:00:00 AM
ATNX News: Athenex Announces Recent Product Launches in 503B and Specialty Injectables Business Units 02/13/2018 08:00:00 AM
PlusOneCoin Top Posts
No plusone'd posts yet. Be the first!
PostSubject
#5  Sticky Note DCTH acquisition/strategic partnership with ATNX imminent Leotrader211 02/02/18 07:03:48 AM
#9   Delcath - Pivotal ICC Trials/ Gemcitabine / Athenex Leotrader211 02/13/18 09:37:08 PM
#8   The Athenex factory – supported by a $200 Leotrader211 02/07/18 08:01:47 AM
#7   Due Diligence on DCTH: Leotrader211 02/06/18 08:33:17 AM
#6   Companies are exploring the clinical benefits of fusing Leotrader211 02/05/18 01:23:00 PM
#5   DCTH acquisition/strategic partnership with ATNX imminent Leotrader211 02/02/18 07:03:48 AM
#4   Delivery of shares today! Could be very JJAAMMAANN 01/29/18 06:40:57 PM
#3   DCTH acquisition/strategic partnership with ATNX imminent  Leotrader211 01/29/18 07:07:14 AM
#2   Why is Dr. Pedder on DCTH board? Leotrader211 01/18/18 02:43:25 PM
#1   Appears to be a very positive news for Leotrader211 01/18/18 02:39:03 PM
PostSubject